KP Tissue Releases First Quarter 2025 Financial Results

Core Insights - KP Tissue Inc. reported strong Q1 2025 financial results, with Adjusted EBITDA of $75.8 million, a 12.9% increase year-over-year, and revenue growth of nearly 14% [3][5][9] Financial Performance - Revenue for Q1 2025 was $546.1 million, up from $479.4 million in Q1 2024, marking an increase of $66.7 million or 13.9% [5][8] - Cost of sales increased to $451.0 million in Q1 2025 from $394.0 million in Q1 2024, reflecting a rise of $57.0 million or 14.5% [6] - Selling, general and administrative (SG&A) expenses rose to $51.2 million in Q1 2025, an increase of $7.1 million or 16.1% compared to Q1 2024 [7] - Net income for Q1 2025 was $15.4 million, compared to $9.0 million in Q1 2024, an increase of $6.4 million [10][12] Segment Performance - The Consumer segment revenue was $465.2 million in Q1 2025, up from $404.3 million in Q1 2024, while the Away-From-Home (AFH) segment revenue increased to $80.9 million from $75.1 million [36] - Adjusted EBITDA for the Consumer segment was $76.1 million, compared to $62.7 million in the previous year, while the AFH segment saw a decrease in Adjusted EBITDA to $2.8 million from $7.8 million [37] Operational Developments - The newly deployed LDC paper machine in Sherbrooke is expected to meet all in-house paper requirements starting Q2 2025, contributing to operational efficiency [3] - The company is closely monitoring the impact of changing tariffs on its business and has developed contingency plans [3] Liquidity and Dividends - Total liquidity as of March 31, 2025, was $356.8 million, with $4.4 million held for the Sherbrooke Expansion Project [11] - A quarterly dividend of $0.18 per share has been declared, to be paid on July 15, 2025 [13]